News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shawver Laura
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 26,107 shares
@ $7.0103, valued at
$183k
Sold 18,897 shares
@ $7.0631, valued at
$133.5k
Exercised 26,017 options to buy
@ $1.27, valued at
$33k
Exercised 18,897 options to buy
@ $1.27, valued at
$24k
|
|
| 08/03/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 18,715 shares
@ $7.1908, valued at
$134.6k
Sold 36,281 shares
@ $7.0909, valued at
$257.3k
Exercised 18,715 options to buy
@ $1.27, valued at
$23.8k
Exercised 36,281 options to buy
@ $1.27, valued at
$46.1k
|
|
| 07/07/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 26,520 shares
@ $6.725, valued at
$178.3k
Sold 31,112 shares
@ $6.414, valued at
$199.6k
Sold 33,510 shares
@ $6.343, valued at
$212.6k
Exercised 26,520 options to buy
@ $1.27, valued at
$33.7k
Exercised 31,112 options to buy
@ $1.27, valued at
$39.5k
Exercised 33,510 options to buy
@ $1.27, valued at
$42.6k
|
|
| 06/28/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/02/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 73,059 shares
@ $6.8, valued at
$496.8k
Sold 26,941 shares
@ $6.95, valued at
$187.2k
Exercised 73,059 options to buy
@ $1.27, valued at
$92.8k
Exercised 26,941 options to buy
@ $1.27, valued at
$34.2k
|
|
| 06/01/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 05/26/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Gifted 12,099 shares
@ $0 |
|
| 05/10/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 43,896 shares
@ $4.58, valued at
$201k
Sold 57,100 shares
@ $6.16, valued at
$351.7k
Sold 42,900 shares
@ $5.31, valued at
$227.8k
Exercised 57,100 options to buy
@ $1.27, valued at
$72.5k
Exercised 42,900 options to buy
@ $1.27, valued at
$54.5k
|
|
| 08/09/2022 |
4
| Shawver Laura (CEO) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Exercised 78,740 options to buy
@ $1.27, valued at
$100k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Shawver Laura (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 41,597 options to buy
@ $17.33, valued at
$720.9k
|
|
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Shawver Laura (CEO) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 27,500 shares
@ $0
Granted 165,000 options to buy
@ $4.85, valued at
$800.3k
Granted 104,500 options to buy
@ $4.85, valued at
$506.8k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Shawver Laura (CEO) has filed a Form 4 on Silverback Therapeutics, Inc.|
Txns:
| Granted 562,631 options to buy
@ $21, valued at
$11.8M
|
|
| 12/03/2020 |
3
| Shawver Laura (CEO) has filed a Form 3 on Silverback Therapeutics, Inc. |
| 07/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/13/2020 |
4
| Shawver Laura (Director) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Granted 10,700 options to buy
@ $18, valued at
$192.6k
Granted 18,300 options to buy
@ $18, valued at
$329.4k
|
|
| 07/09/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/24/2020 |
4
| Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Gifted 80,706 shares
@ $0
Unknown transaction of 220,595 shares
@ $68, valued at
$15M
Unknown transaction of 25,000 shares
@ $68, valued at
$1.7M
Disposed/sold 293,177 options to buy
@ $0.93, valued at
$272.7k
Disposed/sold 172,264 options to buy
@ $0.63, valued at
$108.5k
Disposed/sold 385,185 options to buy
@ $11, valued at
$4.2M
|
|
| 01/02/2020 |
4
| Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Paid exercise price by delivering 210,010 shares
@ $70.63, valued at
$14.8M
Exercised 98,462 options to buy
@ $0.93, valued at
$91.6k
Exercised 12,912 options to buy
@ $0.93, valued at
$12k
Exercised 147,264 options to buy
@ $0.63, valued at
$92.8k
Exercised 120,815 options to buy
@ $11, valued at
$1.3M
|
|
| 12/19/2019 |
4
| Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Granted 45,000 shares
@ $0 |
|
| 01/25/2019 |
4
| Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Exercised 25,000 shares
@ $0.63, valued at
$15.8k
Exercised 25,000 options to buy
@ $0.63, valued at
$15.8k
|
|
| 12/07/2018 |
4
| Shawver Laura (President and CEO) has filed a Form 4 on Synthorx, Inc.|
Txns:
| Granted 506,000 options to buy
@ $11, valued at
$5.6M
|
|
| 12/06/2018 |
3
| Shawver Laura (President and CEO) has filed a Form 3 on Synthorx, Inc. |
| 02/04/2014 |
4
| Shawver Laura (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Disposed/sold 20,000 options to buy
@ $5.42, valued at
$108.4k
Disposed/sold 15,000 options to buy
@ $8.34, valued at
$125.1k
|
|
| 05/23/2013 |
4
| Shawver Laura (Director) has filed a Form 4 on CORNERSTONE THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $8.34, valued at
$125.1k
|
|
| 06/08/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2012 |
3
| Shawver Laura (Director) has filed a Form 3 on CORNERSTONE THERAPEUTICS INC |
|
|